AstraZeneca Targets $80bn Sales By 2030 But Analysts Still To Be Convinced

 
• By Andrew McConaghie
AstraZeneca Discovery Centre Cambridge
AstraZeneca's Discovery Centre in Cambridge, UK

More from Business

More from Scrip